Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
المؤلفون الرئيسيون: | , , , , , , , , , , |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Oxford University Press
2022
|